Over the past 12 months, $VERA has been mentioned 6 times by 2 distinct FinTwit voices, with the first mention appearing on 2025-10-01. The biotech sector voice @adamfeuerstein (Adam Feuerstein ✡️) dominated the conversation with 5 mentions, while @alphaticaio (Alphatica) contributed 1 mention. The most recent activity occurred on 2026-07-07, centered around FDA approval news for the company's kidney disease treatment.

On 2026-07-07, both voices posted about regulatory developments for $VERA. @adamfeuerstein posted multiple updates about the FDA approval, while @alphaticaio noted the approval as a significant event worth attention. The discussion focused on the company's Trutakna treatment receiving FDA clearance for IgAN (immunoglobulin A nephropathy), a kidney disease indication.